Literature DB >> 11988206

Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy).

Andrea S Goldberg1, Murali N Bathina, Steven Mickelsen, Rosella Nawman, Gail West, Fred M Kusumoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11988206     DOI： 10.1016/s0002-9149(02)02285-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department.

Authors:  Thomas A Dewland; Adam Oesterle; John Stein; Gregory M Marcus
Journal:  J Interv Card Electrophysiol       Date:  2017-06-10       Impact factor: 1.900

Review 2.  [Modern pharmacotherapy of supraventricular and ventricular cardiac arrhythmia. An update for conventional therapy].

Authors:  D Steven; B Lutomsky; T Rostock; S Willems
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

3.  Underuse of Catheter Ablation as First-Line Therapy for Supraventricular Tachycardia.

Authors:  Lucas Hollanda Oliveira; Mateus Dos Santos Viana; Christian Moreno Luize; Ricardo Sobral de Carvalho; Claudio Cirenza; Cristiano de Oliveira Dietrich; Luis Claudio Correia; Claudio das Virgens; Juliana Medeiros Filgueiras; Mauricio Barreto; Emerson Porto; Enia Coutinho; Ângelo de Paola
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

Review 4.  Better Lesion Creation And Assessment During Catheter Ablation.

Authors:  Saurabh Kumar; Chirag R Barbhaiya; Samuel Balindger; Roy M John; Laurence M Epstein; Bruce A Koplan; Usha B Tedrow; William G Stevenson; Gregory F Michaud
Journal:  J Atr Fibrillation       Date:  2015-10-31

5.  Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia.

Authors:  Kathryn A Wood; Anita L Stewart; Barbara J Drew; Melvin M Scheinman; Erika S Froëlicher
Journal:  Heart Lung       Date:  2009-09-30       Impact factor: 2.210

6.  Patient's age rather than severity of the arrhythmia influences the cost of medical treatment of atrioventricular nodal or atrioventricular reciprocating tachycardia.

Authors:  Michal M Farkowski; Mariusz Pytkowski; Aleksander Maciag; Dominik Golicki; Ilona Kowalik; Marcin Czech; Piotr Rucinski; Hanna Szwed
Journal:  J Interv Card Electrophysiol       Date:  2016-08-03       Impact factor: 1.900

7.  Assessment of the neutrophil/lymphocyte ratio in patients with supraventricular tachycardia.

Authors:  Mesut Aydın; Abdülkadir Yıldız; Murat Yüksel; Nihat Polat; Adem Aktan; Yahya İslamoğlu
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

8.  Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire.

Authors:  Philippe-Richard Domeyer; Smaragda Ch Giannakidou; Panagiota Kyriakou; Vasiliki Katsari; Antonios P Antoniadis; Ioannis K Lagos; Nikolaos Fragakis; Agoritsa Varaklioti; Vassilios P Vassilikos
Journal:  Biomed Res Int       Date:  2018-10-09       Impact factor: 3.411

9.  Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias (COBRA-PATH): a randomized controlled trial.

Authors:  Tamas Geczy; Nawin L Ramdat Misier; Tamas Szili-Torok
Journal:  Trials       Date:  2020-04-09       Impact factor: 2.279

10.  Health care centre and emergency department utilization by patients with episodes of tachycardia.

Authors:  Ann-Katrin Nordblom; Gabriella Norberg Boysen; Mia Berglund; Anna Kjellsdotter
Journal:  BMC Cardiovasc Disord       Date:  2022-03-23       Impact factor: 2.298
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.